Humana Inc vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $45.51. The key difference: Humana Inc pays a 0.92% dividend while Vanguard Global ex-US Real Estate Index Fd ETF pays none, and Humana Inc is trading nearer its 52-week high, Vanguard Global ex-US Real Estate Index Fd ETF nearer its low. Which is the better fit depends on your goals.
| HUM | VNQI | |
|---|---|---|
Market Cap | $46.31B | — |
Sector | Health | — |
52-Week High | $409.42 | $50.76 |
52-Week Low | $163.67 | $43.26 |
Enterprise Value | $53.67B | — |
Dividend Yield | 0.92% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
VNQI, the Vanguard Global ex-U.S. Real Estate ETF, trades at $46.23, up 0.72% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF provides diversified exposure to international real estate markets across more than 30 countries, featuring a low expense ratio and higher dividend yield compared to U.S.-focused peers, though recent performance has lagged domestic alternatives in total returns.
The outlook for VNQI hinges on global real estate recovery and currency movements, offering yield and diversification benefits amid geopolitical and economic risks. Key risks include foreign market volatility and interest rate sensitivity, while analyst sentiment is mixed due to weaker historical returns versus U.S. counterparts.
Trailing returns across standard periods
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →